Fulcrum Therapeutics, Inc. (FULC) vs Sagimet Biosciences Inc. (SGMT)
A side-by-side comparison of Fulcrum Therapeutics, Inc. and Sagimet Biosciences Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
FULC
Fulcrum Therapeutics, Inc.
$3.69HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
SGMT
Sagimet Biosciences Inc.
$8.78HealthcareDelayed quote: Oct 6, 2026, 3:35 PM EDT
Total return — FULC vs SGMT
growth of $100 · dividends reinvested · last 3yFULC +0.8% (+0.3%/yr)SGMT -43.4% (-17.3%/yr)FULC compounded faster over this window
FULC SGMT
FULC vs SGMT: by the numbers
- •SGMT is the larger company ($286M vs $282M market cap).
Metrics side by side
Valuation
| Metric | FULC | SGMT |
|---|---|---|
| P/B ratio | 0.91 | 1.12 |
Profitability
| Metric | FULC | SGMT |
|---|---|---|
| Gross margin | 0.00% | 0.00% |
| Operating margin | 0.00% | 0.00% |
| Net margin | 0.00% | 0.00% |
| ROE | -27.36% | -18.38% |
| ROIC | -27.62% | -20.40% |
Growth (annualized)
| Metric | FULC | SGMT |
|---|---|---|
| Total return CAGR (5Y) | -31.70% | N/A |
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.